This website uses cookies for anonymised analytics and for account authentication. See our privacy and cookies policies for more information.

The voice of Scotland’s vibrant voluntary sector

Published by Scottish Council for Voluntary Organisations

TFN is published by the Scottish Council for Voluntary Organisations, Mansfield Traquair Centre, 15 Mansfield Place, Edinburgh, EH3 6BB. The Scottish Council for Voluntary Organisations (SCVO) is a Scottish Charitable Incorporated Organisation. Registration number SC003558.

£1 million funding up for grabs as charity marks World Cancer Day

This news post is over 1 year old

Making a difference for a quarter of a century

To mark World Cancer Day (4 Feb), breast cancer charity Walk the Walk has announced it will be awarding £1 million of grants from its reserves during 2023.

The charity raises money through its iconic walking events, including The MoonWalk, which celebrates its 25th anniversary on Saturday 20 May.

Over the last quarter century, Walk the Walk, founded by Nina Barough CBE, has already made a huge difference to people living with cancer and their families. The money raised has contributed to scientific developments, which have led to better diagnosis and treatment of breast cancer.

With the increased impact of so many people being diagnosed late with secondary cancers, because of the pandemic, people across the country need Walk the Walk’s support more than ever. 

Dr Damir Varešlija, Walk the Walk Fellow and Breast Cancer Now scientist said: “I am honoured to be supported by Walk the Walk to advance our understanding of secondary breast cancer in the brain. They have been supporting ground-breaking breast cancer research for 25 years, where they know it will make the most difference.”

Nina Barough CBE, Founder and Chief Executive of Walk the Walk added: “This World Cancer Day, I am delighted to announce that Walk the Walk will be awarding £1 million from its reserves.  Our aim is to put these funds where they are needed most at what is a difficult time for everyone, with a focus on innovative and pioneering treatment and care. Following the pandemic, and with so many secondary cancers being diagnosed, we want to give our support where it really can make a difference.”